Boston Partners Makes New Investment in Maximus, Inc. $MMS

Key Points

• Boston Partners has made a new investment in Maximus, Inc. by acquiring 307,718 shares valued at approximately $20.98 million, representing 0.54% of the company's stock.
• Maximus, Inc. reported a quarterly EPS of $2.16, exceeding analyst estimates, with a revenue of $1.35 billion for the quarter.
• The company declared a quarterly dividend of $0.30 per share, resulting in an annualized dividend yield of 1.4%.

Boston Partners bought a new position in shares of Maximus, Inc. (NYSE:MMS - Free Report) during the 1st quarter, according to its most recent 13F filing with the SEC. The firm bought 307,718 shares of the health services provider's stock, valued at approximately $20,983,000. Boston Partners owned 0.54% of Maximus as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of MMS. Caitong International Asset Management Co. Ltd raised its holdings in Maximus by 17,533.3% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 529 shares of the health services provider's stock worth $36,000 after buying an additional 526 shares during the period. UMB Bank n.a. raised its holdings in Maximus by 70.2% during the 1st quarter. UMB Bank n.a. now owns 606 shares of the health services provider's stock worth $41,000 after buying an additional 250 shares during the period. GAMMA Investing LLC raised its holdings in Maximus by 67.1% during the 1st quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock worth $50,000 after buying an additional 294 shares during the period. NBC Securities Inc. raised its holdings in Maximus by 114,900.0% during the 1st quarter. NBC Securities Inc. now owns 1,150 shares of the health services provider's stock worth $78,000 after buying an additional 1,149 shares during the period. Finally, Blue Trust Inc. raised its holdings in shares of Maximus by 32.8% in the first quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider's stock valued at $84,000 after purchasing an additional 303 shares during the last quarter. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Maximus

In related news, Director Gayathri Rajan sold 7,913 shares of the firm's stock in a transaction on Friday, May 30th. The shares were sold at an average price of $72.38, for a total value of $572,742.94. Following the completion of the transaction, the director directly owned 14,205 shares of the company's stock, valued at approximately $1,028,157.90. This trade represents a 35.78% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.60% of the company's stock.

Maximus Stock Up 0.1%

Shares of NYSE:MMS traded up $0.0850 during midday trading on Wednesday, hitting $85.0650. The stock had a trading volume of 186,432 shares, compared to its average volume of 569,085. Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $93.94. The company has a quick ratio of 2.27, a current ratio of 2.27 and a debt-to-equity ratio of 0.91. The business's 50-day simple moving average is $73.58 and its 200-day simple moving average is $70.83. The company has a market cap of $4.79 billion, a P/E ratio of 15.67 and a beta of 0.60.

Maximus (NYSE:MMS - Get Free Report) last released its earnings results on Thursday, August 7th. The health services provider reported $2.16 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.77. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The business had revenue of $1.35 billion during the quarter, compared to analysts' expectations of $1.29 billion. During the same period last year, the business earned $1.74 earnings per share. The firm's revenue was up 2.5% on a year-over-year basis. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. On average, sell-side analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Sunday, August 31st. Investors of record on Friday, August 15th will be paid a $0.30 dividend. The ex-dividend date of this dividend is Friday, August 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.4%. Maximus's dividend payout ratio (DPR) is currently 22.10%.

Wall Street Analyst Weigh In

Separately, Wall Street Zen downgraded shares of Maximus from a "buy" rating to a "hold" rating in a report on Thursday, May 15th. One investment analyst has rated the stock with a Buy rating, Based on data from MarketBeat, Maximus has a consensus rating of "Buy" and a consensus price target of $90.00.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.